Literature DB >> 19171209

Literature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flow.

Brent Siesky1, Alon Harris, Edward Brizendine, Clarice Marques, Jennifer Loh, Joseph Mackey, Jennifer Overton, Peter Netland.   

Abstract

The purpose of this literature review and meta-analysis was to determine what, if any, effects topical carbonic anhydrase inhibitors have on ocular hemodynamics in humans. A literature review and meta-analysis was conducted to investigate the effects of topical carbonic anhydrase inhibitors on ocular blood flow. Thirty-five articles were evaluated according to the inclusion criteria with 13 manuscripts meeting requirements for statistical analysis. Each study's effect size, defined as the change in blood flow measures after treatment with topical carbonic anhydrase inhibitors, was estimated using the weighted mean difference. Based on this meta-analysis, we conclude that topical carbonic anhydrase inhibitors increase ocular blood flow velocities in the retinal circulation, central retinal and short posterior ciliary arteries, but not in the ophthalmic artery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171209     DOI: 10.1016/j.survophthal.2008.06.002

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  18 in total

1.  Capillary Density Measured by Optical Coherence Tomography Angiography in Glaucomatous Optic Disc Phenotypes.

Authors:  Eren Ekici; Sasan Moghimi; Christopher Bowd; Huiyuan Hou; Rafaella C Penteado; James Proudfoot; Diya Yang; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2020-06-17       Impact factor: 5.258

2.  Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.

Authors:  Yusuke Ohta; Sanae Takaseki; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2017-06-26       Impact factor: 2.447

Review 3.  Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?

Authors:  Ari Stoner; Alon Harris; Francesco Oddone; Aditya Belamkar; Alice Chandra Verticchio Vercellin; Joshua Shin; Ingrida Januleviciene; Brent Siesky
Journal:  Br J Ophthalmol       Date:  2021-08-25       Impact factor: 5.908

4.  Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients.

Authors:  Adam M Moss; Alon Harris; Brent Siesky; Deepam Rusia; Kathleen M Williamson; Yochai Shoshani
Journal:  Clin Ophthalmol       Date:  2010-04-26

Review 5.  [Vasculat treatment concepts in glaucoma patients].

Authors:  Karin R Pillunat; Lutz E Pillunat
Journal:  Ophthalmologe       Date:  2021-05       Impact factor: 1.059

6.  Ganglion Cell Complex Thickness and Macular Vessel Density Loss in Primary Open-Angle Glaucoma.

Authors:  Huiyuan Hou; Sasan Moghimi; James A Proudfoot; Elham Ghahari; Rafaella C Penteado; Christopher Bowd; Diya Yang; Robert N Weinreb
Journal:  Ophthalmology       Date:  2020-01-13       Impact factor: 12.079

7.  Effects of brinzolamide on rabbit ocular blood flow in vivo and ex vivo.

Authors:  Ya-Ru Dong; Shi-Wei Huang; Ji-Zhe Cui; Takeshi Yoshitomi
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

8.  Evaluation of hemodynamic parameters as predictors of glaucoma progression.

Authors:  Ingrida Janulevičiene; Rita Ehrlich; Brent Siesky; Irena Nedzelskienė; Alon Harris
Journal:  J Ophthalmol       Date:  2011-04-10       Impact factor: 1.909

9.  Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension.

Authors:  Parul Ichhpujani; L Jay Katz
Journal:  Drug Healthc Patient Saf       Date:  2010-05-24

10.  Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension.

Authors:  Misha F Syed; Emma Kr Loucks
Journal:  Clin Ophthalmol       Date:  2011-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.